6Sheer TA,Joo E,Runyon BA.Usefulness of serum N-terminal-ProBNP in distinguishing ascites due to cirrhosis from ascites due to heart failure[J].Journal of Clinical Gastroenterology,2010,23(1):774-775.
7Applefeld JJ,Kasmer RJ,Hak LJ.A dose-response study of orally administered torsemide in patients with ascites due to cirrhosis[J].Alimentary Pharmacology and Therapeutics,2008,36 (3):524-526.
8Moon C, Jung K S, Kim D Y, et al.Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin[J].Dig Dis Sci, 2014, 19(3): 154-156.